Ticker Symbol: HRMY

Harmony Biosciences Holdings Inc

$41.13 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001802665

Company Profile

Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: www.harmonybiosciences.com

CEO: N/A

Tags:

Health Technology
Pharmaceuticals: Major
Manufacturing
Medicinal and Botanical Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST

Previous Close: $21.11

Change: -$9.15 ( -30.25%)

Days Range: $18.61 - $23.74

Beta: 0.79

52wk. High: $62.09

52wk. Low: $18.61

Ytd. Change -91.94%

50 Day Moving Average: $32.61

200 Day Moving Average: $33.94

Shares Outstanding: 60000145

Valuation

Market Cap: 126.7B

PE Ratio: 6.46

EPS (TTM): 3.27

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A